Fourth carcinogen discovered in heart pills used by millions
DMF, as the solvent is known, is classified by the World Health Organization as a probable carcinogen.
USFDA issues 9 observations to Natco Pharma's Kothur facility
"At the end of the inspection, the facility received 9 observations, with no re...
Alembic Pharma gets USFDA nod for Parkinson's disease treatment drugs
Quoting IQVIA sales data, the company said the two products had an esti...
Lupin's Goa facility may face regulatory action, says USFDA
The USFDA has stated that it may withhold approval of any pending applications or supplements in which this facility is listed," it added.
Aurobindo Pharma drops 5% on USFDA observations
Shares of Aurobindo Pharma declined to Rs 605.90.
Alembic Pharma gets USFDA nod for overactive bladder treatment drug
The company has received approval from the USFDA for its abbreviated new drug application (ANDA) Solifenacin Succinate tablets in the strengths of 5 mg and 10 mg.
Swarms of bugs, missing data plague firms now making heart drug
Last month, the FDA posted a list of 43 versions of valsartan and similar drugs that don’t contain carcinogens.
Central Drug Lab says no formaldehyde in J&J's baby shampoo
On March 5, 2019, the Rajasthan Drugs Control Organization had reported presence of formaldehyde in samples of two batches of Johnson's baby shampoo.
Dr Reddy's launches generic testosterone gel in US market
The company's testosterone gel 1.62 per cent, which is a therapeutic equivalent generic version of AndroGel 1.62 per cent of AbbVie Inc, was approved USFDA.
Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service